業績

HOME＞業績＞２０１４年度研究業績
２０１８年度研究業績
２０１７年度研究業績
２０１６年度研究業績
２０１５年度研究業績
２０１４年度研究業績
  1. 浜口 毅, 坂井 健, 野崎 一, 篠原 もえ, 三條 伸夫, 中村 好一, et al. MM2型孤発性Creutzfeldt-Jakob病の臨床的特徴について. NEUROINFECTION. 2014;19(2):209.
  2. 佐藤　克也. プリオン病の新規診断法・治療法への挑戦. NEUROINFECTION. 2014;19(2):158.
  3. Sano K, Atarashi R, Ishibashi D, Nakagaki T, Satoh K, Nishida N. Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion. J Virol. 2014;88(20):11791-801.
  4. Qina T, Sanjo N, Hizume M, Higuma M, Tomita M, Atarashi R, et al. Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open. 2014;4(5):e004968.
  5. Nakamura T, Satoh K, Fukuda T, Kinoshita I, Nishiura Y, Nagasato K, et al. Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease. J Neurovirol. 2014;20(3):269-77.
  6. Homma T, Ishibashi D, Nakagaki T, Satoh K, Sano K, Atarashi R, et al. Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein. Sci Rep. 2014;4:4504.
  7. Homma T, Ishibashi D, Nakagaki T, Fuse T, Sano K, Satoh K, et al. Persistent prion infection disturbs the function of Oct-1, resulting in the down-regulation of murine interferon regulatory factor-3. Sci Rep. 2014;4:6006.
  8. Fukuda Y, Horie N, Satoh K, Yamaguchi S, Morofuji Y, Hiu T, et al. Intra-Arterial Transplantation of Low-Dose Stem Cells Provides Functional Recovery Without Adverse Effects After Stroke. Cell Mol Neurobiol. 2014.
２０１３年度研究業績
２０１２年度研究業績
２０１１年度研究業績
２０１０年度研究業績